SUSTAINABILITY AND ANNUAL OVERVIEW

BIOTICS REIMAGINED

CEO's statement

Embarking on a new chapter for Probi

As we look ahead to 2025, I feel optimistic and determined. The successes of 2024 have set a strong foundation for continued growth and innovation. Through hard work and dedication, we’ve achieved a lot and overcome challenges, bringing us closer together as an organization. Everyone’s contribution has been key to our success. We are entering a new era as a fully owned subsidiary of Symrise following the successful public bid by our main shareholder. However, our commitment to our purpose remains stronger than ever – empowering people to live better lives for longer by taking control of their microbiome.

2024 was an important year for us when we thoroughly evaluated how we want to define ourselves and our offerings. A lot has happened since the company was founded in 1991. Today, Probi is more than probiotics, and we have expanded our research and offerings into adjacent areas. Probi is still a company that leads through research and science, and today we work across the entire biotics field. 

Anita Johansen

”Imagine what we can achieve together as we build on our strong scientific foundation in biotics and embrace the opportunities that lie ahead.”

CEO's STATEMENT

THE YEAR IN BRIEF

Net Sales

0

SEK m

Available in

>

0

markets worldwide.

A total of

0

registered patents.

Net sales

SEK m

Net sales

Total emissions in CO2 equivalents

tCo2e

Total emissions in CO2 equivalents

PROBI IN BRIEF

Evaluating the biotics market

The interest in biotics is increasing worldwide, and the market is forecasted to continue to grow. More consumers are understanding the importance of gut health and becoming aware of its connection to overall well-being.

Continued advancements in scientific research have shown what a key role the gut microbiome plays for digestive health, immune function - and even cognitive function, mental well-being and metabolic health. Consumer’s growing knowledge on this topic significantly fuels global consumption patterns.

The growing demand for probiotic supplements

In 2024, global retail sales of probiotic supplements reached approximately USD 9.3 billion, according to Euromonitor, which projects an average annual growth rate of 5-6 percent between 2024 and 2029. 

1

USD m

USA

2

USD m

CHINA

3

USD m

ITALY

Distribution of sales of probiotic supplements in the world 2024

Region APAC, 40%

Region Americas, 34%

Region EMEA, 25%

Rest of world, 1%

Supplements in the world 2029 (Based on Euromonitor's projections)

Region APAC, 41%

Region Americas, 34%

Region EMEA, 25%

Rest of the world, 0%

FURTHER RESEARCH ON HEAL9®

Metabolic health launch

A brand new look

Symrise’ takeover offer

THE YEAR IN BRIEF

OUR STRATEGY FOR SUSTAINABLE AND PROFITABLE GROWTH

 

Pioneering biotic solutions from science to sales

Our vision is to improve lives through the science of biotics. Probi’s strategy for sustainable and profitable growth focuses on four key areas: excellence in commercial execution with a customer emphasis, advancements in science and innovation, delivering high-quality, differentiated products, and fostering a strong, healthy organization with employees united by a shared vision to improve health through biotics science.

OUR STRATEGY FOR SUSTAINABLE AND PROFITABLE GROWTH

Region Americas

0

%

of total net sales.

Sales EMEA

0

%

of total net sales.

Sales APAC

0

%

of total net sales.

LEADING THROUGH SCIENCE

 

SCIENTIFIC RESEARCH AS OUR CORE, PRESENT AND FUTURE

Probi’s biotic solutions are scientifically proven to support the body’s natural functions with the potential to enhance human health worldwide. Our commitment to science keeps us at the forefront of developments in biotics, pushing the boundaries of innovation in both existing and new areas. The efficacy of our signature products is validated by rigorous clinical trials that exceed our industry’s standard practices, and no product is ever brought to market without a solid scientific foundation. 


That’s a promise.

LEADING THROUGH SCIENCE

Approved patents

0

covering Probi’s most important markets in the world.

Number of scientific articles

0

published in 2024 with Probi’s proprietary strains.

BRINGING VALUE TO LIFE

 

ONE OF FEW TO HAVE IN-HOUSE PRODUCTION 

Probi is one of the select integrated players with advanced in-house probiotic production. That makes us well positioned to offer unique products according to specific customer needs, formats and market preferences, while allowing us to adapt operations and optimize processes to meet evolving demands.

ONE OF FEW WITH IN-HOUSE PRODUCTION

MANUFACTURING FACILITIES

0

Probi has two production facilities in the USA, in Redmond, Washington and in Lafayette, Colorado

Clickable Image

Sustainability at Probi: Restoring natural balance

In 2024, Probi embraced the philosophy of ”Restoring Natural Balance” as the essence of our sustainability strategy. This approach harmonizes the power of nature and science, guiding us toward net-zero emissions and fostering sustainable growth. Our commitment extends beyond environmental stewardship to address pressing global health challenges through our scientifically backed innovative biotic solutions. 

Our commitment to restoring natural balance

 

We’re dedicated to helping people take control of their microbiome to live better, longer lives. Guided by our ”Restoring Natural Balance” philosophy and aligned with the UN Sustainable Development Goals, we combine innovative solutions, strategic partnerships, and sustainable practices to tackle global health challenges and create a healthier, more resilient world.

At Probi, our sustainability strategy is firmly grounded in our commitment to both our stakeholders and the United Nations’ Sustainable Development Goals. Since 2021, we have aligned our strategy with the UN’s global goals for 2030, ensuring a long-term focus on positive social, environmental, and economic impact.

0

M

lives impacted through our clinically backed biotic solutions.

0

%

Reduced emissions in relation to 2019 baseline.

0

Recall of products in 2024.

SUSTAINABILITY

Gender distribution - Management team

Men, 40%

Women, 60%

Gender distribution - Total employees

Men, 49%

Women, 49%

Other/non-disclosed, 2%

Gender distribution - Managers

Men, 52%

Women, 48%